Nkarta (NKTX) Amortizatization of Intangibles (2019 - 2026)
Nkarta (NKTX) recorded quarterly Amortizatization of Intangibles of $753000.0 in Q1 2026, down 11.93% quarter-over-quarter from $855000.0 in Q4 2025, and up 56.22% on a YoY basis from $482000.0 in Q1 2025.
Nkarta (NKTX) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Nkarta's Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at $753000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 56.22% year-over-year to $753000.0; the TTM figure through Mar 2026 stood at $4.9 million (up 304.25% YoY), while the FY2025 annual figure was $4.6 million, up 100.35% from the prior year.
- Amortizatization of Intangibles was $753000.0 for Q1 2026 at Nkarta, down from $855000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $2.8 million in Q3 2025 to a low of -$2.9 million in Q3 2023.
- Historically, Amortizatization of Intangibles has averaged $627000.0 across 5 years, with a median of $855000.0 in 2025.
- The sharpest annual moves came in 2022 and 2024: Amortizatization of Intangibles jumped 291.17% in 2022, then tumbled 573.11% in 2024.
- A 5-year view of Amortizatization of Intangibles shows it stood at $1.6 million in 2022, then slumped by 64.01% to $569000.0 in 2023, then sank by 573.11% to -$2.7 million in 2024, then jumped by 131.76% to $855000.0 in 2025, then retreated by 11.93% to $753000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $753000.0 (Q1 2026), $855000.0 (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Nkarta | 210.15 Mn | 210.15 Mn | - | 753,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 753,000.00 |
| Mar 31, 2026 | 753,000.00 |
| Dec 31, 2025 | 855,000.00 |
| Dec 31, 2025 | 855,000.00 |
| Sep 30, 2025 | 2.79 Mn |
| Sep 30, 2025 | 2.79 Mn |
| Jun 30, 2025 | 456,000.00 |
| Jun 30, 2025 | 456,000.00 |
| Mar 31, 2025 | 482,000.00 |
| Mar 31, 2025 | 482,000.00 |
| Dec 31, 2024 | -2.69 Mn |
| Dec 31, 2024 | -2.69 Mn |
| Sep 30, 2024 | 1.96 Mn |
| Sep 30, 2024 | 1.96 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | 1.57 Mn |
| Mar 31, 2024 | 1.57 Mn |
| Dec 31, 2023 | 569,000.00 |
| Dec 31, 2023 | 569,000.00 |